Product: Ranitidine 150 mg tablet  Original Supplier's NDC 65162-0253-10  Remedy Repackaged NDC 70518-1714-00
Reason for recall: CGMP Deviation; Received notice from supplier of potential -Nitrosodimethylamine (NDMA) amounts above established levels.
Recall initiated: 20191211
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated